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Abstract The gene trap methodology is a powerful tool to
characterize novel genes and analyze their importance in
biological phenomena. It is based on the use of mouse embryonic
stem cells and reporter vectors designed to randomly integrate
into the genome, tagging an insertion site and generating a
mutation. Theoretically, all the 100 000 genes present in the
mouse genome could be tagged and functionally inactivated at
the same time. Here we describe the basic concepts and
perspectives of this methodology and show some results obtained
by the gene trap approach used to study molecular cascades in
basic cell biology and in developmental processes. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
The worldwide e¡ort aimed at understanding the structural
and the informational content of human and murine genomes
is near to completion. Based on the sequence information,
general conclusions about the genetic complexity of these or-
ganisms can be drawn, but the knowledge of gene function
and its relevance for human diseases will still be unknown.
The general opinion maintains that every gene should be
studied in its natural biological context. In this respect, ad-
vances are tremendous, due to the advent of gene targeting in
mice. Using that approach, mutants have been generated for a
huge variety of genes and their function largely revealed. This
methodology depends a priori on the isolation and molecular
analysis of a given gene. As an example, the speci¢c inactiva-
tion through gene targeting of particular genes, such as tran-
scriptional factors or signaling molecules, has shed new light
on the functional complexity of mammalian development ([1] ;
for a compendium about targeted mutations, see [2^4]). Var-
ious strategies have been used to isolate such genes, starting
from the classic genetic studies in lower organisms, as Droso-
phila melanogaster and Caenorhabditis elegans. The Hox
genes, for example, were initially isolated from the mouse
genome on the basis of their sequence similarities to conserved
sequence motifs within homologous genes of Drosophila.
However, the vast majority of the estimated 100 000 genes
present in the mouse genome have not yet been cloned, which
precludes their disruption by homologous recombination. To
identify and mutate new murine genes, an excellent experi-
mental strategy is the gene trap [5^8]. In our laboratory and
in many others, several genes important for cell metabolism
and embryonic development have been captured and function-
ally analyzed in this way. The purpose of this review is to
summarize the principles, problems and new results of the
gene trap approach. Moreover, we will discuss the advantages
and disadvantages connected with the establishment of large-
scale gene trap strategies and the striking possibility to adapt
the gene trap approach to another organism, Xenopus laevis
[9]. The ¢nal chapter of this review will be dedicated to re-
porting the capture and simultaneous inactivation of two
genes important for basic cell biology and developmental pro-
cesses, Apaf1 and netrin 1, as two examples of successful gene
trapping in our lab.
In our opinion, the generation of gene trap libraries will be
a fundamental step in the future of functional genomics. Mak-
ing these libraries available to the scienti¢c community and
using them to study gene function are primary objectives of
several public and private laboratories. The establishment of
new screening devices for the trapping events will optimize
this technique, decreasing the workload and thereby providing
researchers with an e⁄cient tool for discovering drug targets.
2. Gene trap methodology
The gene trap approach, represented in Fig. 1, is based on
the use of murine embryonic stem cells (ES) and a class of
reporter vectors, that has been designed containing a splice-
acceptor site upstream of the L-galactosidase (lacZ) gene and
the neomycin resistance gene (neo). Integration of these vec-
tors into a genomic locus downstream of a functional pro-
moter results in the generation of a fusion transcript between
the endogenous gene and the lacZ gene. Fusion transcripts
from insertion of these vectors mimic endogenous gene ex-
pression at the insertion locus. This expression can be moni-
tored by visualizing lacZ activity [6,10]. The tagged genes can
be identi¢ed by the use of anchored PCR procedure [11],
performed on the selected ES cell clones. Furthermore, usu-
ally the gene trap vectors will also act as insertional mutagens,
disrupting the endogenous gene function. ES cell lines can be
used as a bridge between genetic manipulation in vitro and
biological analysis in vivo. Indeed, after genetic manipulation
(electroporation or retroviral infection, for a review, see [12]),
the cells remain pluripotent and, when reintroduced into mor-
ulae by embryo aggregation (or into blastocysts by microin-
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jection), they can contribute to all tissues of the mouse includ-
ing the germ line [13]. Using this strategy, the spatial and
temporal expression patterns of the endogenous genes during
embryogenesis and adulthood can be analyzed. The pheno-
typic consequences of the gene trap mutation can also be
investigated.
We have been interested in analyzing the genetic control of
the development of mammalian central nervous system
(CNS). The gene trap is an experimental strategy particularly
promising in mammals, and therefore suited to this purpose.
2.1. Gene trap vectors
As described above, the rationale behind the use of reporter
constructs is to tag and detect cis-regulatory sequences by
locating the reporter gene within an endogenous gene. In cer-
tain integrations, the reporter construct can also disrupt en-
dogenous gene function and can therefore act as a mutagen.
All trapping vectors devised so far consist of modi¢cations on
one basic structure. A transition zone serves to place endog-
enous genomic sequences next to a reporter gene, which is
then brought under their in£uence. The vector can also allow
the selection of insertion events by carrying a reporter gene
that itself serves as a selectable marker. Fig. 2 shows the
schemes of seven selected gene trap vectors used successfully
worldwide. In the vectors that we have been using, the tran-
sition zone contains a splice-acceptor site derived from the
engrailed 2 gene (ei and ee, eng2 intron element and exon
element, respectively). The reporter gene is lacZ and the se-
lectable marker is neomycin phosphotransferase (neo) fused
together into the bi-functional lacZ/neo gene (L-geo). The
presence of an internal ribosomal entry site (IRES) derived
from the encephalomyocarditis virus ensures the reporter and
resistance activity without requiring an in-frame fusion with
the coding region of the endogenous gene (Fig. 2, IRESLgeo,
[14,15]).
To capture genes that are not active in undi¡erentiated ES
cells and could be induced by in vitro di¡erentiation (see
below), Salminen et al. [16] have constructed a new poly(A)
trap vector. In IRESLgalNeo(3pA), the transcription of neo
is under the control of the L-actin constitutive promoter (La),
while the L-gal expression is dependent on the activity of the
trapped gene. The Pax2 splice-donor element follows the bi-
cistronic structure. In IRESLgalNeo(+pA), the independently
transcribed neo gene has its own poly(A) signal. The authors
elegantly showed that the deletion of the poly(A) structure
reduced the number of integrations occurring outside of the
transcription units. Many important genes are known to be
inactive in undi¡erentiated ES cells [17]. When the ES cells are
cultured under conditions which allow di¡erentiation, a 3-fold
increase in positive stained clones is observed with IRESLgal-
Neo(3pA). As a consequence, this vector will be very useful
in the search for genes responding to speci¢c regulatory fac-
tors in vitro or in the identi¢cation of genes speci¢c to early
steps in di¡erentiation pathways.
The plasmid vector PT1Lgeo is one of the ¢rst gene trap
vectors generated by the group of W.C. Skarnes in 1989 and
was successfully used in several laboratories. However, the
lack of the IRES element renders this vector susceptible to
silencing by non-in-frame fusion events within the endogenous
transcript. Wiles and collaborators [18] have recently reported
the establishment of a large-scale gene trap screen in ES cells
using plasmid and retroviral vectors (Fig. 2, PT1Lgeo and
U3Lgeo). The introduction of a trap vector by a retrovirus
to ES cells also has some advantages. The insertional capa-
Fig. 1. Strategy of the gene trap approach. The scheme represents
the strategy used in our laboratory. As an alternative, the insertion
of exogenous DNA into the ES cells genome can be carried out by
retroviral infection. Prescreening approaches could be applied before
selection of recombinant ES clones (2.). The transgenic o¡spring at
(6.) is derived by breeding the chimeric animal (labeled by the dark
stripes) with an inbred strain C57bl/6 or an outbred strain (NMRI).
The progeny will be tested for germ line transmission and hybrid
crosses between F1 littermates will give rise to the homozygous
specimen.
Fig. 2. Examples of gene trap vectors. For references, see text. ei :
eng2 intron; ee: eng2 exon; Lgeo: lacZ^neo fusion; pA: polyadeny-
lation signal; U3: U3 region of enhancerless Moloney murine leuke-
mia; Sup5: E. coli supF tRNA gene; sa: Zfp-40 splicing acceptor;
IRES: internal ribosomal entry site; T, SV40 nuclear transporting
signal; P-neo, neo gene driven by HSV-tk promoter; La: human L-
actin promoter; sd: mouse Pax2 splice-donor site; pgk: phospho-
glycerate kinase promoter.
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Fig. 3. Expression of di¡erent gene trap lines visualized by L-gal activity. (A^D) show a lateral view on day e12.5 embryos. (E^H) show a view
of cross-sectioned pn9 mouse brains. (A) Gene trap line 6B-4 has a widespread expression throughout the embryo, while the dorsal CNS shows
the highest activity level. (B) Gene trap line 9A-33 demonstrates very strong restricted expression in the tegmentum, in the ventral metencepha-
lon and the spinal cord. The most dominant activity is located in the cortical hemispheres. Additional expression domains are heart, liver, spi-
nal nerves and limbs. (C) Gene trap line 3C-40 reveals restricted activity in the developing liver. (D) Gene trap line 2C-98 has restricted expres-
sion in the dorsal telencephalon, the anterior tectum and the eye. (E) Gene trap line 3C-178 shows strong expression in the hippocampus and
weaker activity in the cingular and piriform cortex of the early postnatal brain. (F) Gene trap line 6A-126 exhibits restricted expression into
the striatum and a fainter level of activity in the subventricular zone of the cingular cortex. (G) Gene trap line 9A-196 expression is located in
the subventricular zone of the somatosensory cortex and the hypothalamus. (H) Genetrap line 7B-79 shows, beside regional restricted expres-
sion in the cingular and motor cortex, a broader activity in the thalamus.
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bility is increased to almost 100% and rearrangements at the
site of insertion have been slight [5,19,20]. However, hot spots
for retroviral insertions retain the potential to bias a screen
based on this class of vectors. As an example, the U3Lgeo
vector, from the retroviral class, carries the Lgeo cassette in
the U3 region of an enhancerless Moloney murine leukemia
virus LTR [18,21,22]. When U3Lgeo integrates into an intron,
an exon or a 5P uncoding element of a genomic locus, it results
in a fused Lgeo transcript, which induces dysfunction of the
tagged gene. By the parallel use of PT1Lgeo and U3Lgeo,
Wiles et al. [18] generated 12 000 targeted ES cell lines, most
of them suitable for generation of transgenic animals.
Finally, vectors TS4 and TV2, constructed by Takeuchi et
al. [20,23], represent interesting modi¢cations of the described
master-vectors. TS4 contains the neo gene driven by HSV-tk
promoter (P-neo) and TV2 displays the sequence for the nu-
clear transporting peptide derived from the SV40 large T gene
at the 5P end of the lacZ sequence. The ‘T’ element is expected
to carry the L-gal to the nucleus, facilitating staining detec-
tion.
It should be mentioned that many other vectors have been
successfully used in the gene trap methodology, vectors that
contain only a promoterless neo without lacZ [24,25] and
vectors containing other drug resistant genes (i.e. hygromycin
or phleomycin [26,27]). Skarnes et al. [14] have constructed a
vector (pGT1.8TM) expressing the transmembrane portion of
the CD4 type I protein (TM) fused to Lgeo. Integration of
these vectors into genes that contain a signal sequence, to
cause accumulation into the endoplasmic reticulum (ER), pro-
duces Lgeo insertions in the membrane in an active con¢gu-
ration. Integration of the vectors in genes that lack a signal
sequence produces a fusion protein with an internal TM do-
main. Insertions of this kind expose Lgeo to the lumen of the
ER, where L-gal activity is lost. By this method, it is possible
to detect integrations in genes that encode cell surface pro-
teins, a class of genes previously missed by conventional gene
trap vectors [14]. Good examples of genes captured by this
technique are netrin 1 and neuropilin 2 [28,29].
Finally, Thorey et al. [30] have engineered a gene trap vec-
tor encoding the Cre recombinase, which should be electro-
porated in a particular ES cell line containing in its genome
the neo gene £anked by the loxP elements and followed by the
lacZ gene. Integration of that construct into the genome of
this speci¢c line will allow LacZ expression only when the neo
gene has been removed by Cre-mediated recombination. This
method is devised to trap genes only transiently expressed in
the ES cells, allowing tracking of the cell lineages within cell
populations and tissues in the developing embryo.
2.2. ES cells manipulation and construction of transgenic mouse
lines
Integration of the gene trap vectors in ES cells allows the
establishment of mutated lines and the transmission of these
mutations through the germ line by chimera production (see
Fig. 1). By electroporation, hundreds of potentially mutated
ES cell lines expressing L-gal can easily be established and
identi¢ed in vitro. ES cells are derived from the inner cell
mass of a normal or implantation-delayed blastocyst. They
can be maintained in culture in a pluripotent state with a
normal karyotype on a ¢broblastic feeder layer. Following
manipulation or screening in vitro (see below for selective
prescreening methodologies in vitro), they can be reintroduced
into morulae (by embryo aggregation) from mice of a di¡erent
coat color, where they intermingle with host cells. The ES cells
readily aggregate with morulae; therefore, all that is required
for chimera production is contact of the two cell populations
[31]. Upon transfer to a pseudo-pregnant recipient, the ES
cells participate in normal development of the chimeric em-
bryo and contribute to all cell types, including the germ line.
Once germ line chimeras are obtained, they will be used as a
source for heterozygous mice carrying the inserted trapping
vector. The activity of L-gal can be detected in whole embryos
and in sectioned postnatal tissues by a chemical reaction that
leads to a blue coloring of positive cells (blue cleaved X-gal
substrate). Staining patterns are then classi¢ed for both spa-
tial and temporal di¡erences between strains with particular
attention to the domain of interest of the laboratory. In Fig.
3, we show a collection of expression patterns obtained by
tracking X-gal staining in embryonic and postnatal brain tis-
sues. Since this method utilizes an extremely simple enzymatic
reaction, the full characterization of the expression pattern of
the captured gene can be completed in an e⁄cient manner.
Noteworthy is that our study demonstrates a clear correlation
between the speci¢c vector used and the corresponding expres-
sion patterns in the established mouse lines, as shown in Table
1. As expected from previous studies [16], the IRESLgal-
Neo(3pA), which has been shown to produce more restricted
LacZ staining in vitro than the IRESLgeo vector, also exhibits
a high percentage of restricted expression patterns during
mouse development and in postnatal brains.
It should be mentioned that the expression of the reporter
gene does not faithfully mimic that of the endogenous trapped
gene in some cases. This could be caused, for example, by the
insertional disruption of intronic regulative elements of the
endogenous gene. It is therefore essential to con¢rm the ex-
pression of the trapped gene, once it has been successfully
cloned by in situ hybridization [32].
Table 1
Statistical analysis of LacZ expression patterns shown from mouse gene trap lines generated with di¡erent vectors
Vector Negative (%) Extended (%) Restricted (%) CNS (%)
IRESLgeoa (45) 20 44 36 31
IRESLgalNeo(3pA)b (56) 29 7 64 43
ES cell clones selected on the basis of a restricted LacZ activity pattern (blue staining in only 10% of the colonies in a 2 cm dish and in 50%
of the cells within a colony) under standard/undi¡erentiated culture conditions have been used to generate the mouse lines. The expression pat-
terns have been analyzed during embryonic development at stage e9.5, e12.5 and e15.5 and on brain samples from postnatal day 9 (pn9). The
individual expression patterns of the mouse lines have been classi¢ed into negative, extended (activity in di¡erent cell types, organs and struc-
tures) and restricted (activity restricted to one cell type, organ or structure). Within the restricted patterns, the subgroup of lines showing ex-
pression in the CNS has been determined. The number of analyzed mouse lines is indicated in brackets.
a[14,15].
b[16].
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2.3. Molecular analysis of the trapped gene
At this point, tagged genes can be identi¢ed by the use of
anchored (rapid ampli¢cation of cDNA ends (RACE)) PCR
procedures [11,15,33]. Products could then be cloned, se-
quenced and compared with databases to verify the novelty
of the trapped gene. Fig. 4 shows an example of the RACE
protocol outcome performed in our laboratory. After the ¢rst
strand reaction of the reverse transcriptase (RT), the cDNA
template obtained from the ES cells mRNA is ampli¢ed by
two subsequent rounds of nested PCR. Primers were derived
from the IRES sequence (Fig. 4A). The ampli¢ed products
from several ES cell lines were then blotted and hybridized
with a probe speci¢c for the eng2 splice-acceptor site, 5P up-
stream of the IRES (see Fig. 2, ee of IRESLgeo). In Fig. 4B,
we point out the PCR products, which were successfully
cloned and correspond to portions of the trapped gene. There
are two major problems connected with this approach. First,
the relative amount of fusion mRNA transcribed in the ES
cells could not be high enough to allow a successful ¢rst
strand polymerization. Second, tandem insertion of the vector
into the genome will increase the background of the nested
PCR reactions.
Another problem, connected with the capability of the gene
trap methodology to generate insertional mutagenesis, is the
potential of a genomic locus to undergo splice-around events.
The splice-around phenomenon occurs when the splice-accep-
tor site contained in the vector is ignored by the spliceosome.
This could happen in 100% of the cases, rendering the inte-
gration completely silent and therefore not interfering with the
screening procedure. In the worst scenario, a splice-around
event could occur only in a time- or space-restricted manner
during developmental or adult tissues, generating a complete
absence of phenotype. For this reason, it is essential to per-
form a molecular analysis of the transcriptional fusion at the
integration site, by RT-PCR or Northern blot, whenever an
expression pattern is considered to be interesting for pheno-
typic analysis. However, the possibility to generate a hypo-
morphic allele could be intended as an advantage, providing
investigators with a variety of di¡erent insertional mutations
of the same gene.
3. Prescreening of gene trap events
On the basis of the expression patterns revealed by the
tagged genes, a large screen of the adult CNS has recently
been performed by Steel and coworkers [34], taking advantage
of mouse lines previously generated [35]. Four trapped genes
showed interesting expression patterns in the mouse hippo-
campus. Those were phenotypically analyzed for involvement
in synaptic plasticity (see below). In our laboratory, several
gene trap lines have been selected for expression in the em-
bryonic and postnatal CNS and are undergoing phenotypic
analysis (see Table 1; [36,37]).
However, the possibility to screen by expression pattern
analysis in embryonic or adult tissues is severely hampered
by space limitation of the mouse colony, which could render
the strategy too di⁄cult for speci¢c purposes.
An area of growing interest is the possibility of directing ES
cells along speci¢c lineages, such as the neuronal lineage. In
the absence of feeder layers or DIA/LIF, ES cells have the
capacity to di¡erentiate into many cell types in vitro, either
spontaneously or induced by chemical agents such as neuro-
trophic factors [10,38]. In aggregates of di¡erentiated ES cells,
embryoid bodies contain other various di¡erentiated cells
such as hematopoietic cells, muscle cells and chondrocytes
[39^42]. The gene trap methodology has been adapted to
use after a prescreening for genes activated during these di¡er-
entiating conditions [24,43^47].
ES cell clones could also be a priori classi¢ed, according to
their subcellular staining distribution: di¡use, nuclear, cyto-
plasmic and surface-localized. For instance Skarnes and col-
laborators [14] have planned a novel gene trap strategy,
named secretory trap, which is based on a new class of vectors
(see above) and this subcellular localization prescreening.
These approaches will comprehensively allow for identi¢ca-
tion and insertional mutation of genes whose expression is
modulated during development and the di¡erentiation of sev-
eral tissues and organs.
4. Gene trap in Xenopus
The amphibian transgenesis procedure, set up by Kroll and
Amaya [48], is a rapid and e⁄cient protocol suitable for mul-
ti-generation experiments, which does not give rise to mosaic
germ line in the founder [9]. The Xenopus transgenic technique
is not based on ES cell establishment, but on a restriction
enzyme-mediated integration by introduction into condensed
sperm nuclei in vitro (REMI [48]). It must be mentioned that
attempts are ongoing to establish in other organisms cell lines
similar to murine ES cells (i.e. in chicken [49]).
To apply the Xenopus transgenic generation to a more wide
gene trap approach, the authors generated a new vector re-
placing the lacZ gene with the green £uorescent protein gene
(GFP), whose expression could be detected in living individ-
uals [9]. The e⁄cacy of the approach was demonstrated by the
generation of hundreds of transgenic embryos, in a few hours,
expressing GFP in many tissue types. The main advantage of
using Xenopus as a target organism is that the embryos devel-
op externally and expression of the marker (GFP) can be
Fig. 4. Selection of trapped cDNAs by nested PCR and Southern
blotting. Electrophoresis on 2% agarose gel of the 5P RACE prod-
ucts from several gene trap lines (A). Co: control on standard
DNA. To size select cDNAs, in order to amplify the most se-
quence-informative fragments, the ¢rst strand RT reactions on ES
cells mRNA were micro-dialyzed. This allowed the discharge of
DNA fragments less than 200 bp. Size-selected cDNAs then under-
went two rounds of nested PCR ampli¢cation and were micro-dia-
lyzed after each round. Lines XIX-18 (Apaf1), EI-9 and 3A-91 were
obtained by electroporation of the IRESLgeo vector into ES cells.
Autoradiography of the Southern blot of the same gel, labeled with
a radioactive probe corresponding to the ee region of the vector (B)
(see Fig. 2). The arrowheads indicate the fragments positive to the
hybridization, which were selected for cloning and consequent iden-
ti¢cation of the trapped gene. The line XXII-5 is shown as an ex-
ample of an unsuccessful 5P RACE approach.
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monitored almost limitlessly. Genotyping of heterozygotes
would also be an easier task, since the positive embryos could
be selected by monitoring GFP expression. The possibility of
obtaining thousands of mutant embryos from a single exper-
imental mating makes this methodology a plausible and
powerful tool for a large-scale functional genomics program.
The tetraploidity of Xenopus, however, can be a negative fac-
tor, as the organism would have a more complex genome
exhibiting functional genetic redundancy [9].
5. Large-scale strategies
Two major strategies have been used in the last 5 years for
creating libraries of gene trap lines and sequences of the
tagged genes. The ¢rst strategy has been organized by a Ger-
man consortium, which has generated a reference library of
gene trap sequence tags (GTST [18]). The second is lead by
Lexicon Genetics (TX, USA). Both approaches are based on a
gene trap sequence screening automated in the 96-well format
and both have the potential to represent insertional mutations
for most of the mammalian genes in mouse ES cells [18,50,51].
While those libraries are on their way to completion, new
databases are being created which will provide a minimal
amount of required data needed, before proceeding to study
the organism in vivo. In the age of functional genomics, those
databases will be an invaluable tool for investigators.
6. Phenotypic analysis: some examples
In favorable cases, considering the redundancy of the mam-
malian genome and the potential of a splice-around event, the
gene trap insertions would lead to a phenotype.
The number of gene trap mouse lines responsible for phe-
notypes is rapidly increasing, from early embryonic lethality
to adult fertility impairment.
Table 2 summarizes the most relevant trapped genes with a
clear phenotype isolated so far.
Friedrich and Soriano [5] were the ¢rst to take advantage of
the gene trap methodology, in their attempt to identify devel-
opmentally regulated genes. To determine whether recessive
phenotypes were associated with mutations in the ‘trapped
genes’, heterozygous mice from 24 strains were intercrossed
and the o¡spring genotyped. Homozygous o¡spring could not
be isolated from nine strains, indicating that the insertions led
to a recessive lethal phenotype. Cloning of one of the trapped
genes, which led to recessive lethal phenotype, indicated that
insertion disrupted the transcriptional enhancer factor 1
(TEF-1) gene. The characterized strain exhibited a phenotype
associated with heart dysfunction; thus their analysis has
shown that TEF-1 plays an essential role in the maturation
stage of cardiogenesis [52]. Another example of the e⁄ciency
of the gene trap strategy has been provided by DeGregori et
al. [25] : an embryonic lethal mutation has been accounted for
by the insertional disruption of the gene fug1, similar to the
RNA1 gene of Saccharomyces cerevisiae. Using a gene trap
strategy, Torres et al. [38] have isolated a mouse mutation
for the gene encoding the K-E-catenin. Catenins are proteins
associated with the cytoplasmic domain of cadherins, a family
of transmembrane cell adhesion molecules. The cadherin^cat-
enin adhesion system is involved in morphogenesis during
development and in maintaining the integrity of di¡erent tis-
sue types. Another mouse mutation, termed jumonji (jmj), was
also generated by a gene trap strategy [23]. Expression of jmj,
as monitored by X-gal staining, was detected predominantly
at the midbrain^hindbrain boundary and in the cerebellum.
The phenotype showed dramatic brain malformations. More
recently, Ross and coworker [53] identi¢ed the anti-apoptotic
factor bcl-w by the gene trap method. The expression of this
gene in the testis appears to be restricted to elongating sper-
matids and Sertoli cells. The authors suggest a role of bcl-w
for germ cell di¡erentiation.
Finally, neuropilin 2, trapped by the secretory trap [14], is a
necessary receptor for a class 3 semaphorin (Sema3F) and
plays important roles in establishing several axonal trajecto-
ries in the developing CNS [29].
In the ¢nal portion of this review, we will focus on two
genes trapped in our laboratory (Apaf1 and netrin 1) which
turned out to be key factors in basic cell biology functions,
cell death and cell adhesion.
6.1. Apaf1
Among several trapped genes isolated and analyzed so far
in our laboratory, Apaf1 (apoptotic protease activating factor
1, reviewed in [54]) is likely to be the most important example.
The gene trap line XIX-18 was selected during an expression
screening in mouse embryos performed at several stages of
development. Strong LacZ expression was detected in the dif-
ferentiating layers of the neural tube, in the ganglion cells
layer of the neuro-retina and in the limbs. After identi¢cation
of the 5P RACE product from the gene trap line XIX-18 as
the murine Apaf1 cDNA homolog (see Fig. 4A,B, second
lanes), we cloned the full length mouse Apaf1 cDNA and
analyzed the embryonic phenotype in mice homozygous for
the insertional mutation [36]. The gene trap insertional muta-
tion generated a null allele, as demonstrated by Northern and
Western blot analysis.
Table 2
Examples of genes isolated and mutated by gene trap
Gene Product LacZa Vector Reference
TEF-1 transcriptional factor extended RosaL-geo [52]
Fug1 RNA1-like extended U3neo [25]
Netrin 1 secreted factor restricted PGT1.8TM [28]
IRESLgeo [37]
K-E-Catenin adhesion molecule restricted PGT1.8geo [38]
Jmj novel restricted TV2 [23]
Bcl-w anti-apoptotic protein restricted RosaL-gal [53]
Apaf1 pro-apoptotic protein extended IRESLgeo [36]
HSP90L Heat-shock protein extended PGT1.8geo [68]
Neuropilin 2 TM receptor extended PGT1.8TM [29]
aLacZ expression pattern analyzed at several stages of development.
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In C. elegans, CED-9 inhibits cell death [55], CED-3 and
CED-4 promote cell death [56,57]. Apaf1 is a CED-4 homolog
and it participates in the cytochrome c/dATP-dependent acti-
vation of a mammalian CED-3 homolog, caspase 3 (Casp3;
[58]), by prior activation of caspase 9 (Casp9; [59]).
Mice in which Casp3 has been deleted by targeted disrup-
tion die perinatally with a massive cell overgrowth in CNS, as
a result of an apoptosis de¢ciency in the neuroepithelial cells
[60]. The Casp9 knockout mice showed the same abnormality
[61]. Obviously, Apaf1 was a good candidate to play a crucial
role in mammalian development, being upstream of Casp9
and Casp3.
Abnormal embryos were found only at e12.5 and later. All
abnormal embryos were homozygous for the Apaf1 mutation,
which is lethal around e16.5. Apaf13=3 embryos at e14.5 show
a characteristic cranio-facial phenotype whose major traits are
facial cleft, absence of the skull vault and of all vomer and
ethmoidal elements, and rostral or dorsal exencephaly (Fig.
5A,B). In addition, Apaf1 mutants show alterations of the
retina, lens and eye vascular system. At e14.5, a hyperplasic
folded retina occupies most of the optic cup (Fig. 5C,D; ret-
inal pigmented epithelium is indicated by the arrowheads).
Apoptosis has been described as a regulator of the cell num-
ber during normal development of the retina (histogenetic cell
death).
From e12.5 onwards, the mutant brain shows important
morphological distortions. The telencephalic vesicles are
folded and reduced in size. Anatomically, the brain hyperpla-
sia of Apaf1 mutants is particularly intense in the diencepha-
lon and the midbrain. Histologically, the hyperplasia is due to
the abnormal proliferation of neural precursor cells and their
irregular distribution in the tissue, as shown by the proneural
marker Delta-1 (Fig. 5E,F). The brain phenotypes in Apaf1,
Casp3 and Casp9 null mutations [36,60,61] are extremely sim-
ilar. In the wild-type CNS but not in the mutant, we observed
numerous active Casp3-immunoreactive cells. These ¢ndings
strongly indicate that these proteins could be components of
the same apoptotic pathway during brain development. This is
consistent with their functional interactions shown in vitro
[58,59].
In summary, Apaf1 is involved in histogenetic cell death
(control of cell number in the developing retina and brain),
morphogenetic cell death (in the neural tube, lens, skull, face
and limbs) and phylogenetic cell death (elimination of the
hyaloid artery system in the developing eye).
The apoptotic machinery or apoptosome, which involves
Apaf1 and many other anti- and pro-apoptotic factors such
as Bcl-XL, Bax and other caspases, could contribute to the
pathogenesis of some neurodegenerative diseases and could be
involved in cancer suppression [62^64]. The identi¢cation and
functional analysis of this gene performed by gene trap could
have provided us with a new drug target for those diseases.
6.2. Netrin 1
By using the secretion trapping protocol, Skarnes et al. [14]
generated a hypomorphic allele of the netrin 1 gene which had
previously been shown to be involved in axon guidance in the
developing neural tube [65,66]. Consistent with these results,
the netrin 1 mutant mice have defects in several major com-
missures of the brain and show misguidance of the spinal
commissural as well as retinal ganglion cell axons [28,67].
Salminen and coworkers [37] independently generated an-
other netrin 1 gene trap mouse line and focused on the im-
portance of netrin 1 in inner ear development. Fig. 5G,H
shows sections of wild-type and mutant inner ears of an
e12.5 mouse embryo. In the mutant ear, the posterior semi-
circular duct (psd) does not form properly, due to the lack of
local disruption in the basement membrane and to the epithe-
Fig. 5. Two phenotypes deriving from gene trap insertional muta-
genesis. The trapped gene Apaf1 regulates apoptosis in mammalian
development (A^F). The Apaf1 de¢cient phenotype exhibits dorsal
exencephaly in a homozygous e14.5 embryo (B) compared with the
wild-type littermate (A). The retinal hyperplasia in the same em-
bryos is also shown. The arrowheads point to the external margin
of retinal pigmented epithelium (C, D). The overgrowth of brain tis-
sues in cross-sections of e12.5 embryos is due to proliferation of
neural precursor cells, as shown by in situ hybridization with the
proneural marker Delta-1. The asterisks show the telencephalic
vesicles, occluded by cells in the mutant (E, F). The secreted mole-
cule netrin 1 (net-1), also trapped by gene trap in our laboratory, is
important for proper development of the inner ear (G, H). Compar-
ison of transverse sections through the wild-type (G) and the mu-
tant (H) inner ear of an e13.5 embryo shows impaired formation of
the posterior semicircular duct (psd). Psd is part of a precisely or-
ganized epithelial labyrinth essential for balance.
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lial^mesenchymal mis-signaling caused by netrin 1 de¢ciency.
These ¢ndings imply a new morphological role for netrin 1.
7. Concluding remarks
The production of Apaf1 and netrin 1 gene trap mutants
represents a good example of how genetically modi¢ed ES cell
libraries can be used to rapidly and e⁄ciently generate and
analyze mouse mutants. New vectors, designed for more spe-
ci¢c approaches, together with novel prescreening techniques,
will contribute to optimize this strategy by reducing workload
and time consumption. The large-scale e¡orts carried out
worldwide to create gene trap libraries, which could saturate
the mammalian genome, will increase the ability to study gene
activity in depth, and will provide us with the compelling
perspective needed to associate such genes to human diseases.
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